The Mouse Gastrointestinal Bacteria Catalogue enables translation between the mouse and human gut microbiotas via functional mapping.

by Beresford-Jones, Benjamin S, Forster, Samuel C, Stares, Mark D, Notley, George, Viciani, Elisa, Browne, Hilary P, Boehmler, Daniel J, Soderholm, Amelia T, Kumar, Nitin, Vervier, Kevin, Cross, Justin R, Almeida, Alexandre, Lawley, Trevor D, Pedicord, Virginia
Published 2021

The Mouse Gastrointestinal Bacteria Catalogue enables translation between the mouse and human gut microbiotas via functional mapping.

by Beresford-Jones, Benjamin S, Forster, Samuel C, Stares, Mark D, Notley, George, Viciani, Elisa, Browne, Hilary P, Boehmler, Daniel J, Soderholm, Amelia T, Kumar, Nitin, Vervier, Kevin, Cross, Justin R, Almeida, Alexandre, Lawley, Trevor D, Pedicord, Virginia A
Published 2022

Two microbiota subtypes identified in irritable bowel syndrome with distinct responses to the low FODMAP diet.

by Vervier, Kevin, Moss, Stephen, Kumar, Nitin, Adoum, Anne, Barne, Meg, Browne, Hilary, Kaser, Arthur, Kiely, Christopher J, Neville, B Anne, Powell, Nina, Raine, Tim, Stares, Mark D, Zhu, Ana, De La Revilla Negro, Juan, Lawley, Trevor D, Parkes, Miles
Published 2021

Two microbiota subtypes identified in irritable bowel syndrome with distinct responses to the low FODMAP diet.

by Vervier, Kevin, Moss, Stephen, Kumar, Nitin, Adoum, Anne, Barne, Meg, Browne, Hilary, Kaser, Arthur, Kiely, Christopher J, Neville, B Anne, Powell, Nina, Raine, Tim, Stares, Mark D, Zhu, Ana, De La Revilla Negro, Juan, Lawley, Trevor D, Parkes, Miles
Published 2022

The MITRE trial protocol: a study to evaluate the microbiome as a biomarker of efficacy and toxicity in cancer patients receiving immune checkpoint inhibitor therapy.

by Thompson, Nicola A, Stewart, Grant, Welsh, Sarah, Doherty, Gary, Robinson, Matthew J, Neville, B Anne, Vervier, Kevin, Harris, Simon R, Adams, David J, Dalchau, Katy, Bruce, David, Demiris, Nikolaos, Lawley, Trevor D, Corrie, Pippa G
Published 2022

The MITRE trial protocol: a study to evaluate the microbiome as a biomarker of efficacy and toxicity in cancer patients receiving immune checkpoint inhibitor therapy.

by Thompson, Nicola A, Stewart, Grant D, Welsh, Sarah J, Doherty, Gary J, Robinson, Matthew J, Neville, B Anne, Vervier, Kevin, Harris, Simon R, Adams, David J, Dalchau, Katy, Bruce, David, Demiris, Nikolaos, Lawley, Trevor D, Corrie, Pippa G
Published 2022